Compare OVV & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVV | MEDP |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.9B |
| IPO Year | 2019 | 2016 |
| Metric | OVV | MEDP |
|---|---|---|
| Price | $55.42 | $452.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | $52.77 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 4.9M | 368.0K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | 13.54 | ★ 20.98 |
| EPS | 4.78 | ★ 15.28 |
| Revenue | ★ $8,908,000,000.00 | N/A |
| Revenue This Year | N/A | $13.11 |
| Revenue Next Year | $6.47 | $7.51 |
| P/E Ratio | ★ $11.53 | $31.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.80 | $250.05 |
| 52 Week High | $55.14 | $628.92 |
| Indicator | OVV | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 74.52 | 39.15 |
| Support Level | $36.96 | $418.96 |
| Resistance Level | N/A | $470.79 |
| Average True Range (ATR) | 1.61 | 16.34 |
| MACD | 0.15 | 6.41 |
| Stochastic Oscillator | 91.46 | 48.02 |
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.